ACB Earnings Date: Nov 4, 2026 (Estimated) — Aurora Cannabis Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is ACB's next earnings date?
Aurora Cannabis Inc. (ACB) is expected to report earnings on Wednesday, November 4, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.03 on revenue of $50.7M.
How did ACB do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q1 2027), Aurora Cannabis Inc. posted EPS of -$0.05 versus the -$0.13 estimate, a beat of 61.5%. Revenue was $48.8M against a $47.4M estimate. The stock's 1-day post-earnings move was +3.6%.
How much does ACB stock move after earnings?
ACB beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 13.7% (up or down) in the day after earnings.
About Aurora Cannabis Inc.
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q1 2027 | -0.13 | -0.05 | +61.54% | $48.8M | ✅ Beat | +3.56% | +24.02% | +43.42% |
| 2026-06-11 | Q4 2026 | -0.07 | -0.35 | -400.00% | $61.8M | ❌ Miss | -6.38% | -11.25% | -18.84% |
| 2026-02-04 | Q3 2026 | 0.19 | 0.02 | -88.95% | $67.6M | ❌ Miss | -7.64% | -12.32% | -13.79% |
| 2025-11-05 | Q2 2026 | 0.02 | -0.19 | -1050.00% | $65.6M | ❌ Miss | -1.76% | +0.22% | +0.66% |
| 2025-08-06 | Q1 2026 | 0.18 | -0.19 | -205.56% | $70.8M | ❌ Miss | -7.93% | +14.57% | +5.00% |
| 2025-06-18 | Q4 2025 | 0.11 | -0.24 | -318.18% | $63.1M | ❌ Miss | -20.41% | -33.33% | -22.96% |
| 2025-02-05 | Q3 2025 | 0.04 | 0.41 | +925.00% | $63.1M | ✅ Beat | +45.92% | +74.46% | +32.34% |
| 2024-11-06 | Q2 2025 | -0.21 | 0.04 | +119.05% | $59.5M | ✅ Beat | -16.20% | -22.59% | -28.64% |
Showing last 8 quarters.
Revenue by segment & region
By region
FY2026 · $176.5M total · annual
| Segment | Share | Revenue | YoY | FY2020 | FY2021 | FY2022 | FY2025 |
|---|---|---|---|---|---|---|---|
| Europe | 74.7% | $131.8M | +58.2% | — | — | — | $83.3M |
| AUSTRALIA | 22.1% | $39.0M | — | — | — | — | — |
| NEW ZEALAND | 3.2% | $5.6M | — | — | — | — | — |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.